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ABSTRACT 
The encapsulation of protonated ellipticine (EH
+
) in the cavity of cucurbit[8]uril (CB8) was 
studied in water at pH 4 with spectrophotometric, fluorescence spectroscopic and isothermal 
calorimetric measurements. The formation of three types of inclusion complexes was observed 
depending on the host and guest concentrations. Not only one but also two EH
+
 was capable of 
encapsulation in CB8 in 37 M EH+ solution and the thermodynamics of the binding steps were 
revealed. The produced very stable complexes showed markedly different absorption and 
fluorescence properties. When large excess of CB8 was employed in dilute (0.49 M) EH+ 
solution, sequential binding of two CB8 occurred to the monomer alkaloid bringing about a 
substantial alteration in the fluorescence decay kinetics. The driving force of the 1:2 guest:host 
complex formation was much lower than that of 1:1 encapsulation.  
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1. Introduction 
The inclusion complex formation of cucurbiturils (CBn) with compounds of pharmaceutical 
importance has attracted widespread attention because of its great potential in drug delivery (1-4) 
and development of sensitive analytical methods (5-8). These macrocyclic hosts are nontoxic and 
capable of traversing the cell membrane (9-11). The confinement of drugs in CBn cavity not only 
enhances the solubility (12,13) and thermal stability (14), but also hinders the decomposition 
(15,16). For example, the nucleophilic addition reaction and photooxidation of sanguinarine, a 
biologically active natural benzophenanthridine alkaloid, are inhibited by the embedment in 
cucurbit[7]uril (CB7) macrocycle (17). The microenvironment-sensitive fluorescent properties of 
berberine were used to examine the encapsulation and dissociation kinetics with CBn cavitands 
(18,19) .  
Due to its anticancer (20) and antimalarial (21) activity, ellipticine (E) has been 
extensively investigated, and the intricate mechanism of its biological effect has been revealed 
(22). E has a very low water solubility of ~6.2×107 M at neutral pH (23,24), but more than 3 
orders of magnitudes higher concentration can be the reached upon the protonation of the 
pyridine moiety. The conjugate acid has a pKa value of 7.4 ± 0.1 in 0.025 M buffers (25). The 
fluorescent behavior of E was examined in organic solvents of a wide range of polarities and 
hydrogen bonding capabilities (26). The effect of interaction between the NH group of E and 
hydrogen bond acceptors on the absorption and fluorescence characteristics was revealed. 
Photoinduced deprotonation was found in acetonitrile only with a very strong base, 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU), due to the extremely weak acidity of the NH moiety of E 
even in the singlet-excited state (27). Therefore, photoinitiated tautomerization via intramolecular 
proton transfer from the pyrrolic NH to the nitrogen of the pyridine ring cannot occur. The lack 
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of such a tautomerization was proved by the analogous fluorescence properties of E and its 6-
methyl derivative (ME), which does not contain any dissociable hydrogen (28,29).  
The encapsulation of the protonated form of ellipticine (EH
+
) in cucurbiturils has been 
examined, and only 1:1 complex formation was reported with both CB7 and cucurbit[8]uril 
(CB8) despite the substantial change of the fluorescence decay parameters upon gradual increase 
of host concentration (30). The main goals of the present studies were to understand the CB8 
concentration dependence of the kinetics of EH
+
 fluorescence and to identify the various 
fluorescent species. We reveal how the amounts of EH
+ 
and CB8 in the solutions affect the 
stoichiometry and thermodynamics of inclusion complex formation. The formulae of the 
investigated compounds are presented in Figure 1. 
 
2. Experimental 
Ellipticine (≥99% by HPLC, Fluka) was used as received. High-purity CB8 was kindly provided 
by Dr Anthony I. Day (University of New South Wales, Canberra, Australia). Experiments were 
performed in double-distilled water at pH 4. Slightly more than stoichiometric amount of 
concentrated HCl aqueous solution was added to ellipticine in ethanol. The solvent and the 
excess of HCl were evaporated. EH
+
Cl

 salt prepared thereby was dissolved in 10
4
 M HCl 
aqueous solution. The UV-visible absorption spectra were measured on an Agilent Technologies 
Cary60 spectrophotometer. Corrected fluorescence spectra were recorded on a Jobin-Yvon 
Fluoromax-4 photoncounting spectrofluorometer. No photodecomposition occurred when EH
+ 
aqueous solutions were irradiated in the sample holder of the spectrofluorometer in the presence 
and absence of CB8. Fluorescence decays were collected with time-correlated single-photon 
counting technique using the previously described instrument (31). The results of 
spectrophotometric and fluorescence titrations were analysed with homemade programs written 
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in MATLAB 7.9 analogously to that reported in a former paper (31). Starting with the initial 
estimates of the binding constant, the concentrations of the various species were calculated as 
numerical solutions of the mass balance equations and the definition of the binding constants. 
Then, the fluorescence intensity or absorbance values were calculated, and the iterations were 
repeated until the best fit was achieved. Isothermal titration calorimetry was carried out with a 
VP-ITC (MicroCal) instrument at 298 K as described (19). 
 
3. Results 
3.1 Inclusion complex formation with CB8 at low EH
+
 concentration  
To avoid dimerization, 0.49 M total protonated ellipticine  concentration was used in the study 
of the interaction with CB8. Calculations using the recently published dimerization constant 
((1.4 ± 0.3) × 104 M1) showed that less than 2% of the alkaloid molecules are associated in such 
a dilute solution (32). Gradual addition of CB8 to EH
+
 solution at pH 4 brought about an 
intensity enhancement and a hypsochromic shift in the fluorescence spectrum indicating 
complex formation (Figure 2A). The plot of the intensity at 530 and 560 nm as a function of 
CB8 concentration exhibits two distinct domains. The steep initial rise is followed by a much 
slower intensity enhancement suggesting sequential binding of two CB8 cavitands. The 
equilibrium constants are defined as 
𝐾11 =
[𝐸𝐻+−𝐶𝐵8]
[𝐸𝐻+][𝐶𝐵8]
     (1) 
𝐾12 =
[𝐸𝐻+−(𝐶𝐵8)2]
[𝐸𝐻+−𝐶𝐵8][𝐶𝐵8]
    (2) 
The results presented in Figure 2B were analysed by a previously described homemade 
MATLAB 7.9 program (31). The nonlinear fit provided K11 = (1.6 ± 0.2)×10
6
 M
1
 and K12 = 
(5±4)×103 M1, whereas the fluorescence efficiency at 560 nm was about 5-fold larger for 1:2 
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EH
+(CB8)2 complex than that of 1:1 EH
+CB8 complex. The microenvironment of the guest is 
less polar in EH
+(CB8)2 than in water analogously to previous findings (33). Therefore, blue-
shift is observed in the fluorescence spectrum with the increase of CB8 concentration. Time-
resolved fluorescence measurements at 590 nm corroborated the formation of two types of 
inclusion complexes. As expected, the amplitude of the dimer fluorescence was negligible (< 
2%) in 0.49 M EH+ solution. The fluorescence decays could be fitted by a triple-exponential 
function: 
𝐼(𝑡) = 𝑎1 exp (−
𝑡
1
) + 𝑎2 exp (−
𝑡
2
) + 𝑎3 exp (−
𝑡
3
)                                      (3) 
where ai stands for the amplitudes and i denotes the lifetimes. Figure 3 shows the variation of 
the amplitude fractions (ai /ai) in the presence of various amounts of CB8. The monomer 
fluorescence of 2.0 ns lifetime vanished in the presence of large CB8 excess and the concomitant 
emergence of a 3.8 ns lifetime component was observed, which was assigned to singlet-excited 
EH
+CB8. The amplitude of this emission (a2) reached a maximum around 7 M CB8 
concentration and then declined due to the progressive strengthening of a third component of 
16.6 ns lifetime. The longest-lived fluorescence was attributed to EH
+(CB8)2 because its 
amplitude (a3) grew at the expense of a2 at high CB8 concentrations. The substantial difference 
in the initial slope of a2 and a3 increase is in accordance with the more than two orders of 
magnitude larger equilibrium constant of EH
+CB8 formation compared to that of the binding of 
the second CB8. 
To reveal the thermodynamics of EH
+
 inclusion in CB8, the fluorescence titrations 
displayed in Figure 2 were repeated at various temperatures (T). The van’t Hoff plot of the 
derived K11 binding constant is presented in Figure 4. From the slope and intercept, 
± 3 kJ mol
1 
and S11 = 51 ± 7 J mol
1 
K
1
 were calculated for the enthalpy and 
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entropy change in 1:1 hostguest complex formation. The thermodynamic parameters of CB8 
association with EH
+CB8 could not be obtained due to the substantial uncertainty of K12. 
 
3.2 Binding to CB8 at high EH
+
 concentration  
Intriguing absorption and fluorescence characteristics was observed in CB8 solutions containing 
37 M total EH+ concentration. Under this condition, 38% of alkaloid molecules are dimerized 
in the absence of CB8 on the basis of the recently reported association constant of ((KD =1.4 ± 
0.3)×104 M1) (32). Figure 5 displays the change of the absorption spectra and the absorbance at 
327 nm upon increase of the amount of CB8 in the solution. The experimental data demonstrate 
that different species dominate at 22 and 97 M CB8 concentrations. This conclusion was 
corroborated by the results of fluorescence titration. (Figure 6) The apparent blue shift of the 
fluorescence maximum in the presence of 97 M CB8 originated from the dissociation of the 
(EH
+
)2 dimer upon complex formation with CB8. To identify the binding processes, 
fluorescence decay measurements were performed at 530 nm. The biexponential fluorescence 
intensity versus time profile arising from monomer and dimer EH
+
 became triple exponential in 
the presence of CB8. Below 30 M CB8 concentration, lifetimes of 2.0, 3.8, and 7.5 ns were 
found. Upon further addition of CB8, EH
+ 
emission vanished, and a very weak emission of 16.6 
ns lifetime emerged. The 2.0, 3.8 and 16.6 ns lifetimes have been ascribed to monomer EH
+
, 
EH
+CB8, and EH+(CB8)2 fluorescence, respectively. (vide supra) These assignments are 
corroborated by the variation of the amplitude fractions displayed in Figure 7.  
The intensity of 2.0 ns lifetime component progressively diminishes and disappears 
above 30 M CB8 concentration because all EH+ ions are encapsulated. This trend is 
accompanied by the parallel growth of the amplitude fraction of EH
+CB8 emission (2= 3.8 
ns), which dominates at high CB8 concentrations. The EH
+(CB8)2 fluorescence component 
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(3= 16.6 ns) is much weaker than at low EH
+
 concentration because of the smaller molar excess 
of CB8. The amplitude of 7.5 ns emission goes through a maximum as a function of CB8 
concentration implying the formation of (EH
+
)2CB8 and its conversion into EH
+CB8. The 
confinement in CB8 insignificantly affects the fluorescence lifetime of (EH
+
)2. No evidence was 
found for 2:2 binding. The Job plot of the absorbance change is presented in Figure S1 in 
Supporting Information. Among the experimentally detected species, the following association 
equilibriums are possible: (Figure 8) 
Because the fluorescence decay traces showed very small amounts of EH
+(CB)2 in 37 
M EH+ solution over the entire CB8 concentration range, its formation was neglected in the 
evaluation of the experimental data presented in Figures 5 and 6. Our goal was to reveal the 
binding equilibriums resulting in (EH
+
)2CB8. This ternary complex may be produced (i) by 
consecutive binding of two in CB8, (ii) by direct inclusion of (EH+)2 dimer or (iii) both 
processes may take place. First, we assumed that consecutive binding of two  occursThe 
reaction between (EH
+
)2 andCB8 was eliminated and the experimental data were fitted with a 
MATLAB program developed on the basis of the remaining equilibriums. K11 was known from 
the independent experiments at 0.49 M EH+ concentration, whereas the molar absorption 
coefficient ratio at 327 nm (/
 = 3.52) and the relative fluorescence efficiency at 
530 nm (f((EH
+
)2)/f(EH
+
) = 2.10) for (EH
+
)2 and EH
+
 as well as the association constant of 
(EH
+
)2 dimer formation, KD were taken from measurements carried out in the absence of CB8. 
The nonlinear regression analysis of the spectrophotometric and fluorescence titration data at 37 
M EH+ concentration gave K21 = (4.2 ± 0.8) × 10
4
 M
1 
and the computed functions matched the 
experimental data well (insets to Figures 5 and 6). 
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 In the second step, we assumed that (EH
+
)2CB8 is formed only in the association of 
(EH
+
)2 with CB8. Thus, the complex formation between EH
+
 and EH
+CB8 was eliminated. 
Excellent fit was obtained, and KD1 = (5.2 ± 0.95) × 10
6
 M
1
 was found for the equilibrium 
constant of (EH
+
)2 dimer confinement in CB8. This KD1 value corresponded to that calculated 
using K21, K11, and KD values given in Table 1 by the relationship  
𝐾𝐷1 = 𝐾21𝐾11/𝐾𝐷             (4) 
Supporting Information shows the derivation of eq 4. This relationship is valid if the cycle of 
equilibriums shown in Figure 8 exists. The good match of the KD1 value obtained in the second 
analysis step and KD1 derived by eq 4 indicates that not only the consecutive encapsulation of 
two EH
+ 
but also the direct (EH
+
)2CB8 formation with the interaction of (EH
+
)2and CB8   
occur. The calculated binding constants are summarized in Table 1.  
NMR measurements in the presence of 190 M CB8 confirmed the inclusion complex 
formation. Higher CB8 concentration could not be employed because of the low solubility of 
CB8 even in the presence of EH
+
. The NMR spectra are displayed in Figure S4 in Supporting 
Information. 
 
3.3 Determination of the thermodynamic parameters of inclusion at high EH
+
 concentration  
Isothermal calorimetric measurements at pH 4 gave information on the thermodynamics of 
complex formation. Figure S2 in Supporting Information displays the experimental results for 
the titration of 124 M CB8 to 8.0 M EH+ solution at 298 K. Exothermic complexation was 
observed. The data were consistent with a sequential binding to two sites model. To decrease the 
number of fitted parameters, K11 and K21, were taken from Table 1 and kept constant. The 
nonlinear least-squares analysis led to the thermodynamic quantities listed in Table 2.  
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 To verify the calorimetric results, the spectrophotometric titrations presented in Figure 5 
were repeated at various temperatures. At each temperature the experimental data were fitted 
keeping K11 and KD fixed at the value calculated on the basis of the calorimetric determined 
enthalpy and entropy changes. H and S for the formation of EH+CB8 is given in Table 2, 
whereas these quantities for EH
+
 dimerization were taken from a recent paper (32). The van’t 
Hoff plot of the calculated K21 binding constants is shown in Figure S3 in Supporting 
Information. The thermodynamic parameters derived therefrom are included in Table 2. The 
results derived from fluorescence or spectrophotometric titrations agree, within the limits of 
experimental errors, with the data obtained by calorimetric measurements.  
 
4. Discussion 
Our results demonstrate that the binding of EH
+
 both to CB8 and to EH
+CB8 are enthalpically 
driven processes. Despite the 38-fold larger stability constant of the 1:1 complex, the inclusion 
of the first EH
+
 is much less exothermic than the second binding step. Substantial entropy gain 
contributes to the driving force of 1:1 encapsulation, whereas 2:1 complexation is entropically 
highly unfavourable. The removal of high-energy water molecules from the apolar cavity of 
cucurbiturils was found to play a very important role in controlling the binding strength (33-36).  
The water network is moderately distorted in CB8 (34) and only a fraction of water is expelled 
by the inclusion of EH
+
. Therefore, EH
+CB8 formation is accompanied by a limited enthalpy 
diminution. The energy of the remnant water in EH
+CB8 becomes higher because less 
optimized interactions among the encapsulated water molecules can be developed. 
Consequently, the release of water upon embedment of the second EH
+
 results in more 
substantial enthalpy gain than 1:1 complexation. The transfer of water from the interior of CB8 
and from the hydrate shell of EH
+
 to the bulk leads to entropy enhancement. The entropy loss 
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due to the inclusion does not counterbalance this effect since the loose binding of EH
+
 in the 
spacious CB8 causes relatively small entropy change. In contrast, EH
+
 association with 
EH
+CB8 results in tightly packed complex, in which the degrees of freedom of the constituents 
are highly restricted. Hence, (EH
+
)2CB8 formation is accompanied by a significant entropy 
decrease. The considerably lower binding affinity of EH
+ 
to EH
+CB8 compared with the 
encapsulation in CB8 originates from the very unfavourable entropy contribution to the driving 
force in the former process.  
K11 for EH
+CB8 formation is ca. 6-fold smaller than the corresponding quantity for the 
inclusion of berberine, an isoquinoline alkaloid, in CB8 (18). This difference arises from the 
slightly less negative H11 and the smaller entropy gain for EH
+
 complexation. About 50-fold 
lower K21 value is obtained for (EH
+
)2CB8 (Table 1) compared to the analogous process of 
berberine.(18) Both H21 and S21 are significantly less negative in the case of EH
+
, and the 
enthalpy term dominates to a lesser extent when this alkaloid produces 2:1 complex. The binding 
affinity of EH
+CB8 to CB8 is low because of the electrostatic repulsion between the high 
electron density of oxygens at the portals of the two hosts. Much smaller driving force for 1:2 
complexation compared with 1:1 association was also found when sanguinarine, a natural 
benzo[c]phenanthridine alkaloid, interacted with cucurbit[7]uril (17). 
The results of the present study are in contrast to the conclusions of a former report on 
EH
+ 
confinement in CB8, which suggested only 1:1 complex formation (30). We found about 
7.6-fold larger equilibrium constant for the 1:1 EH
+CB8 inclusion complex formation than the 
2.1×105 M−1 value published by Gavvala and coworkers (30). This discrepancy probably arises 
from the fact that the dimerization of EH
+
 (32) and the encapsulation of two EH
+
 in the cavity of 
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CB8 were not previously taken into account. The substantial variation of the fluorescence decay 
parameters is due to the change of the binding stoichiometry with host and guest concentrations.  
 
Supplementary Information 
Supplemental data for this article can be accessed http:// 
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